Nikita I. Bychkovskii

Nikita I. Bychkovskii

Auto-generated profile, based on publicly available information

Nikita I. Bychkovskii

Burdenko Neurosurgical Center

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
AAA.D. Akhmedov
A.D. Akhmedov
Yuri M. PoluektovYuri M. Poluektov
Yuri M. Poluektov
NBN.I. Bychkovskii
N.I. Bychkovskii
VKV.P. Kondratev
V.P. Kondratev
BZB.A. Zakirov
B.A. Zakirov
NKN.A. Konovalov
N.A. Konovalov
Background. Cervical lipomas accompanied by neurovascular compression are extremely rare and require surgical treatment in case of appropriate symptoms. The preferable method is gross total resection, as otherwise they tend to recur. Invasive growth is not typical for lipomas. However, large tumors can involve adjacent nerves and vessels and significantly complicate resection. Material and methods. We present a 57-year-old patient who underwent resection of giant soft tissue cervical lipoma invading neurovascular bundle and compressing the oropharynx and esophagus with dysphagia and positional asphyxia. The patient was followed-up for previous 5 years. Resection was necessary due to tumor enlargement with appropriate symptoms. Searching for literature data was performed in the Pubmed, Medline, EMBASE, Cochrane Library and eLibrary databases. Results and discussion. Gross total resection of 7-cm tumor was accompanied by mobilization of hypoglossal and vagus nerves, common, external and internal carotid arteries and jugular vein with repositioning of the oropharynx and esophagus. There was mild Horner’s syndrome in early postoperative period. The patient was discharged in 4 days after surgery with regression of complaints. We found only 5 reports describing giant cervical lipomas invading neurovascular bundle. Conclusion. Giant cervical lipomas are extremely rare, and total resection with preservation of critical structures is possible in a specialized hospital.

4 April 2025 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
Yuri M. PoluektovYuri M. Poluektov
Yuri M. Poluektov
AKAnton Konovalov
Anton Konovalov
MRM.V. Ryzhova
M.V. Ryzhova
NBN.I. Bychkovskii
N.I. Bychkovskii
NLN.V. Lasunin
N.V. Lasunin
DKD.S. Kim
D.S. Kim
In 2021, a new type of tumor was defined according to the new WHO classification (high-grade astrocytoma with piloid features, HGAP). Morphological and neuroimaging differences of HGAP from pilocytic astrocytoma complicate diagnosis. Now, significant detection of this tumor is possible only using molecular genetic testing, in particular, methylation profile analysis. Objective. To present a patient with HGAP and perform a systematic review of studies devoted to adults with HGAP regarding clinical course, diagnosis, protocols and treatment outcomes. Material and methods. Selection of studies was carried out in accordance with the PRISMA recommendations. The authors analyzed the studies independently of each other. All data were systematized. A case report was described jointly with attending physicians and pathologists. Results and discussion. HGAP is characterized by rapid progression and resistance to therapy. This case illustrates the importance of awareness of neurosurgeons and necessitates molecular genetic tests to identify this group of tumors. Conclusion. HGAP is a rare and aggressive tumor. Treatment algorithm for such patients has not yet been developed. The world experience of treatment is presented by individual series. Analysis of methylation profile is necessary for patients with atypical course of tumors similar to pilocytic astrocytoma.

23 April 2024 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
AKAnton Konovalov
Anton Konovalov
EBE.S. Brinyuk
E.S. Brinyuk
Yuri M. PoluektovYuri M. Poluektov
Yuri M. Poluektov
SKS.V. Kaprovoy
S.V. Kaprovoy
ROR.A. Onoprienko
R.A. Onoprienko
NBN.I. Bychkovskii
N.I. Bychkovskii
Searching of literature data revealed only a few reports devoted to long-term postoperative outcomes in patients with lumbosacral spine synovial cysts. These results are ambiguous and largely contradictory. Objective. To analyze the long-term postoperative outcomes in patients with lumbosacral spine synovial cysts. Material and methods. A retrospective observational cohort study was performed between January 2015 ando September 2022. The study included patients who underwent surgical treatment for lumbosacral spine synovial cysts with clinical and neurological manifestations. There were 94 medical records of respondents (36 (38.3%) men and 58 (61.7%) women aged 18-82 years). Mean postoperative follow-up period was 24.6±7.5 months. Results. Patients underwent various surgical interventions for synovial cysts. VAS scores of pain syndrome after 3, 6, 9, 12 and 24 postoperative months revealed significant pain relief in the lower back and extremities (p<0.01). In long-term follow-up period, we observed significantly lower disability (Oswestry Disability Index) (p<0.001). Adverse postoperative events occurred in 9 (9.6%) cases. Conclusion. Interlaminectomy with cyst wall resection and preservation or partial resection (no more than 1/3) of facet joint without segmental fusion is an effective and preferable surgical method with minimal incidence of adverse clinical events.

15 December 2023 in Russian Neurosurgical Journal named after Professor A. L. Polenov
Verified
Journal Article
Open access
PDF file
AKAnton Konovalov
Anton Konovalov
Yuri M. PoluektovYuri M. Poluektov
Yuri M. Poluektov
DAD. S. Asuytin
D. S. Asuytin
SKS. V. Kaprovoi
S. V. Kaprovoi
ESE. V. Sergeenko
E. V. Sergeenko
NBN. I. Bychkovsky
N. I. Bychkovsky
SUMMARY. Extradural and intramedullary tumors are classified as intradural neoplasms of the spinal cord. The median approach followed by laminectomy is considered to be the traditional approach to removal of intradural neoplasms of the spinal cord. In recent decades, hemilaminectomy has become the most commonly used technique due to its many benefits. Traditionally, hemilaminectomy was performed through a median approach, however, this approach limited the viewing angle in patients with ventrally located neoplasms. The use of paramedian approaches for tumors located ventrally and ventrolaterally from the spinal cord improves the view and angle of surgical attack.OBJECTIVE. To conduct a comparative analysis of paramedian and posterior minimally invasive approaches in the surgical treatment of ventral and ventrolateral tumors, as well as to compare the effectiveness and safety of their use in terms of the radical removal of the tumor, the time of operation, the volume of intraoperative blood loss, the time spent in the hospital, postoperative liquorrhea, the time of suturing solid meninges (dura mater), the severity of postoperative pain syndrome according to the visual analogue scale (VAS) and the assessment of quality of life according to the EQ-5D-5L VS scale.MATERIAL AND METHODS. One hundred twenty-one (121) patients with vental and ventro-lateral intradural extramedullary tumors were treated in spinal department of Burdenko Neurosurgical Center between 2016 and 2020. The study included only patients with extramedullary neoplasms that did not extend to more than 1 segment of the spine, patients with tumors of the upper cervical spine were excluded. The median age of the patients was 49[20;81]. The average follow-up period was 12±3 months. The patients were divided into 2 groups: the first group (group I) of 53 patients underwent minimally invasive tumor removal with hemilaminectomy and partial joint resection window via paramedian approach, the second group (group II) of 68 patients underwent minimally invasive tumor removal through the hemilaminectomy window using the posterior approach. After surgery, the radicality of tumor removal, the time of the operation, the volume of intraoperative blood loss, in-hospital stay, postoperative liquorrhea, time for duraplasty, and severity of postoperative pain syndrome according to VAS were estimated. The degree of tumor resection was assessed by MRI with intravenous contrast. Time for dura suturing and sealing was estimated using intraoperative videorecording.RESULTS. The Group of patients underwent surgery with paramedian approach (I group) showed a decrease in the duration of surgery (90±34 to 95±39 min), a decrease in the frequency of postoperative liquorrhea (2 to 6 cases) and provides better view on the ventral and ventrolateral tumors, that, in turn, improves the treatment radicality. The time of in-hospital stay was equal between groups (4±1 to 5±1 days), volume of intraoperative blood loss was equal in both groups (55±19 to 54±15 ml). The severity of pain syndrome on the first day was slightly higher in the I group (3.1±0.8 to 2.9±0.7 points), but on the third day, the results did not differ significantly (2.2±0.7 to 2±0.7 points). Also, it was found that the paramedian approach provides a better intraoperative view of the lesions of the ventral and ventrolateral localization and allows the paramedian incision of the dura mater to be performed, which in turn reduces the time required for suturing and sealing the dura mater 8.7±3.7 to 12±3.9 min.CONCLUSION: The use of minimally invasive paramedian approach for ventral and ventrolateral extramedullary intradural tumors surgery is an effective method that provides better angle of surgical attack and allows to increase safety and radicality of tumor resection.

30 May 2025 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
MKM.O. Kudymets
M.O. Kudymets
AKAnton Konovalov
Anton Konovalov
SKS.V. Kaprovoy
S.V. Kaprovoy
ROR.A. Onoprienko
R.A. Onoprienko
AKA.B. Kozlova
A.B. Kozlova
NBN.I. Bychkovskii
N.I. Bychkovskii
Despite modern advances in neurosurgery, treatment of intramedullary spinal cord tumors is still associated with postoperative neurological impairment and high incidence of adverse outcomes. Intraoperative neurophysiological monitoring allows real-time functional assessment of spinal cord conduction pathways and accurate tumor resection. Currently, concomitant monitoring of somatosensory and motor evoked potentials, as well as D-wave is the most common. This excludes damage to both sensory and motor pathways. In modern literature, there are some differences in methods of intraoperative neurophysiological monitoring, such as sensitivity and specificity of the method, criteria of «alarm» during surgical treatment of intramedullary tumors and correlation of neurophysiological monitoring parameters with postoperative neurological status of patients.

24 November 2025 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
YKYulia V. Koledova
Yulia V. Koledova
NBNikita I. Bychkovskii
Nikita I. Bychkovskii
VMVladimir Mitkevich
Vladimir Mitkevich
AMAlexander Makarov
Alexander Makarov
Yuri M. PoluektovYuri M. Poluektov
Yuri M. Poluektov
Introduction: Advances in molecular biology and biotechnology in recent decades have led to creation of new therapeutic strategies for Alzheimer’s disease (AD) patients. Among the emerging therapeutic approaches, monoclonal antibodies are attracting particular attention due to their ability to modulate the accumulation of amyloid plaques and tau protein in the brain, thus proposing promising pathogenetic approach. Aim: to summarize efficacy, side effects and mortality rates of monoclonal antibodies based on the results of clinical trials in comparison with conventional therapy. Methods: All registered clinical studies related to AD treatment using monoclonal antibodies were found in ClinicalTrials.gov database. The information on adverse effects was obtained from the articles related to the third phase clinical studies, with total 21 articles included in the analysis. Data on conventional therapy were retrieved from clinical guidelines related to AD treatment. Results: We found that the number of significant side effects and mortality varies significantly for different monoclonal antibodies. For the most part, side effects are not specific to the drugs used, and therefore it is not possible to assess the direct effect of the drug on the development of certain adverse events, as well as to adequately compare the safety of different drugs, due to different mechanisms of action and recommended doses. Magnetic resonance imaging with estimation of amyloid-related imaging abnormalities changes is the most promising method for antibodies comparison, but this approach still lacks correlation with clinical course. Also, it is recommended to separately consider the side effects associated with infusion. Conclusion: The use of pathogenetic antibody therapy will improve the quality of AD treatment in the future. However, up to date, there are no unified protocols for estimation of drug effectiveness and its comparison. Evaluation of side effects and determination of antibody-specific side effects is necessary to improve the safety of treatment of patients with AD.